Citations

Clear

16280 citation(s) found for "Yu, David".

Sympathetic Vasoconstrictive Responses during Exercise- or Drug-Induced Vasodilatation
Rowlands, D. J., Donald, David E.

Mayo Clinic

Circulation Research | June 12, 2012 | Volume: 23 | Issue: 1 | Pages: 45-60

10.1161/01.res.23.1.45 | PMID 5661938 Get It

The effect of exercise on the vasoconstrictive response to sympathetic stimulation was studied by observing the changes in perfusion pressure in dogs' hindlimbs perfused at constant flow. During steady-state simulated exercise, a time-dependent increase occurred between 10 and 30 minutes in the magnitude of response to lumbar trunk stimulation or carotid sinus hypotension. This was present (although to a reduced Degrees) in drug-induced vasodilatation and in exercising limbs perfused at constant pressure. The time-dependent change was not due to (1) repetition of stimulus, (2) artifact from muscle electrodes, (3) circulating vasoactive substances, (4) skin circulation, or (5) pH, P CO 2 , or temperature of the perfusing blood. When norepinephrine was used as the vasoconstrictive stimulus, no time-dependent change was noted. After stabilization, the frequency-response curve of exercising muscle exceeded that at rest at all blood concentrations of norepinephrine and at all save the lowest frequencies of stimulation. It was concluded that vascular smooth muscle can develop greater tension from greater initial length. However, during exercise some factor which operates between the sympathetic nerve ending and the receptor site on vascular smooth muscle initially tends to depress this enhanced ability to develop tension.
Effect of Beta-Adrenergic Receptor Blockade on Racing Performance of Greyhounds with Normal and with Denervated Hearts
Donald, David E., Ferguson, David A., Milburn, Sidney E.

Mayo Clinic

Circulation Research | June 12, 2012 | Volume: 22 | Issue: 2 | Pages: 127-134

10.1161/01.res.22.2.127 | PMID 5639034 Get It

A field study was made of the effect of β-adrenergic receptor blockade (propranolol; Kö 592) on the racing performance of six normal greyhounds and three with chronic extrinsic cardiac denervation. Records were made of the time to race a 5/16-mile course before and after blockade; the heart rate was recorded by telemetry. After the administration of the β-adrenergic receptor-blocking agent to the normal greyhound, racing time was slightly increased, and maximal heart rate was slighdy decreased. After blockade in the cardiac denervated greyhounds, racing time was prolonged, cardiac acceleration was severely limited, and the animals finished running in a state of collapse. The data indicated diat die cardiostimulant action of both sympathetic nerves and circulating catecholamines was necessary for maximal performance. After blockade of one or the other of these mechanisms, racing performance was slightly reduced from normal. Withdrawal of both adjuvants severely limited the performance of maximal exercise.
Atrial Contribution to Stroke Volume in Dogs with Chronic Heart Block
Snyder, J. H., Kitchin, A H, Zitnik, Ralph S., Donald, David E., Wood, Earl H., Bender, Franz

Mayo Clinic

Circulation Research | June 12, 2012 | Volume: 19 | Issue: 1 | Pages: 33-41

10.1161/01.res.19.1.33 Get It

In dogs studied without thoracotomy, under morphine-pentobarbital anesthesia and with an average heart rate of 71 beats/minute, atrial systole contributes to ventricular function to a small but significant degree. Stroke volume increased by 7 to 8% when atrial systole was timed to occur 0.1 second prior to closure of the atrioventricular valves, and decreased a similar magnitude when the contribution of atrial systole to ventricular filling was rendered ineffective by the use of an A-V delay of zero so that atrial emptying into the ventricles was prevented by the closed A-V valves. Increases or decreases in right atrial pressure of several centimeters of water induced by infusion of 6% dextran and by hemorrhage, respectively, were not associated with demonstrably significant alterations in these effects.
Comparison of Dilution Technics Using Aortic Injection with Upstream Sampling for Assessment of Aortic Regurgitation
Armelin, E, Donald, David E., Wood, Earl H.

Mayo Clinic

Circulation Research | June 12, 2012 | Volume: 15 | Issue: 4 | Pages: 287-300

10.1161/01.res.15.4.287 | PMID 14220885 Get It

The distances between the aortic valve and sites in the aorta from which no retrograde flow of injected indicator could be detected in the left ventricle were determined, without thoracotomy, in two normal dogs and in ten dogs with chronic experimental aortic regurgitation. It was found that these distances attained maximal values when the aortic injections were timed to occur just at the end of systole or onset of diastole. Distances downstream from the origin of the left subclavian artery from which no retrograde flow occurred to this vessel were determined similarly in these same animals and, in confirmation of Warner and Toronto, similar relationships to the timing of the injections were obtained. These distances down the aorta, designated as "disappearance distances", were converted to "disappearance volumes" by measuring the diameters of the silhouette of successive aortic segments from aortograms made after contrast medium was injected into the left ventricle of these animals. The regurgitant flow through the aortic valve per heartbeat was estimated on the basis of the amount of immediately appearing indicator detected in the left ventricle following injection of indicator approximately 1 cm downstream from the aortic valve. Correlation coefficients of 0.88 and 0.77 were obtained between these stroke-regurgitation values and the disappearance volumes from the aortic valve and subclavian artery, respectively. The standard errors of the estimate of the regurgitant flow per beat from these regression equations were ± 2.7 and ± 2.9 ml/beat, respectively. The correlation coefficients between stroke-regurgitation values and the disappearance distances from the valve and subclavian artery were 0.83 and 0.81, respectively, and the respective standard errors of the estimate of stroke regurgitation from these regression equations were ± 3.2 and ± 3.3 ml/beat. It is concluded that determination of the maximal distances downstream in the aorta of sites from which retrograde flow of injected indicator can be detected in the left ventricle or subclavian artery is a valid method for estimating the severity of experimental aortic regurgitation in dogs. Since determinations of the disappearance distance from the aortic valve can be carried out readily in conjunction with measurement of the left ventricular regurgitation fraction, it is suggested that advantage be taken of the increase in reliability which accrues from the combined use of these two independent methods for the estimation of the degree of aortic regurgitation.
Assessment of an Indicator-Dilution Technic for Quantitating Aortic Regurgitation by Electromagnetic Flowmeter
MALOOLY, DONALD A., Donald, David E., Marshall, Hiram W., Wood, Earl H.

Mayo Clinic

Circulation Research | June 12, 2012 | Volume: 12 | Issue: 5 | Pages: 487-507

10.1161/01.res.12.5.487 Get It

The square-wave electromagnetic flowmeter was used to assess the upstream sampling dye-dilution technic for quantitating aortic regurgitation by simultaneous determinations of the regurgitant fraction by flowmeter, as given by the ratio of regurgitant volume to total stroke volume (RV/TSV) and the identical ratio of regurgitant flow to total forward flow (Q R /Q F ), and the regurgitant fraction by dye curve, as given by the ratio of the areas of the immediately appearing portion of the left ventricular curve to the area of the femoral artery dye curve (LV A /FA A ), after injection of indicator approximately 1 cm downstream to the aortic valve. A good correlation (r = 0.91) was found between these two independent methods which can be represented by the regression equation Q R /Q F = 0.82 (LV A /FA A ). This correlation indicates that the concept that the regurgitant fraction of indicator (LV A /FA A ) is proportionate to the regurgitant fraction of blood (RV/TSV) is valid. The observed systematic difference between flow-meter and dye-curve regurgitant fractions may be due to the fact that time-average rather than volume-average concentrations of the indicator are obtained by sampling of blood through eatheters. Two different and independent calibration technics were used to establish a calibration factor for converting recorded flowmeter deflections to volumetric units for measurement of rates and volumes of blood flow in the ascending aorta. The first technic involved simultaneous recording of dye-dilution curves and velocity pulses in the ascending aorta by the flowmeter before the production of aortic regurgitation. The second involved bidirectional perfusion of the isolated aorta at known rates of blood flow with simultaneous flowmeter recordings at the termination of each experiment. The data obtained validated the use of the flowmeter for measurements of total stroke volume and regurgitant stroke volume. The close correspondence between flowmeter recordings of the regurgitant flow and hydraulic estimates of regurgitant flow, based on the size of the defect in the aortic valve measured at necropsy and continuous records of the pressure gradient across the valve, also lent strong support to the validity of these measurements. The relationship Q R = Q S (Q R /Q F )/(1 - Q R /Q F ) can be used to estimate regurgitant flow from values of the regurgitant fraction (Q R /Q F ) and the systemic flow (Q S ). The mathematical relationship of the regurgitant fraction to regurgitant flow, determined by the dilution-curve technic, plus the variability obtained between simultaneous flowmeter and dilution-curve estimates of regurgitation, indicate that the error in the estimation of regurgitant flow by the dye-dilution technic is least for small-to-moderate degrees of regurgitation and increases progressively with the severe degrees of regurgitation associated with regurgitant fractions of greater than 0.6. On the basis of 231 simultaneous determinations by the indicator-dilution and flowmeter technics carried out in nine dogs, and assuming that the flowmeter values were uniformly correct, it was estimated that the standard deviation of the errors in measurement of regurgitant flow by the upstream sampling dye-dilution method in these experiments was 0.15 L per minute for regurgitant fractions below 0.6. and that this variability increased so that the standard deviation was 1.3 L per minute at regurgitant fraction levels of 0.9 to 1.0. The results of determinations carried out over a range of heart rates from 39 to 216 beats per minute indicate that the indicator-dilution method is applicable over a wide range of heart rates. The observed changes in aortic regurgitation with variation in heart rate correlated closely with the changes estimated by hydraulic equations based on the hydrodynamics of steady flow through an orifice. The increase in regurgitant stroke volume with increased duration of diastole at slow heart rates was disproportionately greater than the increase in total stroke volume, so that the effective forward (systemic) flow fell to extremely low levels at slow heart rates, particularly in dogs with large defects in the aortic valve. The applicability of the upstream sampling indicator-dilution technic to the detection and estimation of the severity of aortic regurgitation in human beings merits further study.
Detection and Measurement of Experimentally Produced Aortic Regurgitation by Means of Indicator-Dilution Curves Recorded from the Left Ventricle
Armelin, E, Michaels, Leon, Marshall, Hiram W., Donald, David E., CHEESMAN, RICHARD J., Wood, Earl H.

Mayo Clinic

Circulation Research | June 12, 2012 | Volume: 12 | Issue: 3 | Pages: 269-290

10.1161/01.res.12.3.269 Get It

In dogs studied without thoracotomy the detection of immediately appearing indicator in the left ventricle following its injection approximately 1 cm downstream from the aortic valve can be used as a reliable index of the presence or absence of aortic regurgitation. With this type of injection and under the conditions of these experiments, the ratio of the area encompassed by the immediately appearing portion of the dilution curve recorded from the left ventricle to the area encompassed by the primary portion of the curve recorded at the femoral artery bears a close positive correlation (correlation coefficient: 0.9) to the severity of aortic regurgitation as estimated by back perfusion of the valve at necropsy. Within limitations, the position of the tip of the sampling catheter in the left ventricle in dogs with aortic regurgitation is not an important determinant of the amount of immediately appearing indicator detected in this chamber. Furthermore, although the amount of indicator detected in the left ventricle following injections of very short duration is time-dependent, if the duration of the injection is extended to cover the full systolic or diastolic phase of one heartbeat or continues over one or more heartbeats, the exact timing of this injection in relation to the cardiac cycle is not an important determinant of this variable. It is concluded that under these conditions the positive correlation established between the amount of immediately appearing dye detected in the left ventricle (expressed as the regurgitant fraction) and the severity of aortic regurgitation determined by back perfusion at necropsy can be used as a valid means of estimating the severity of aoritic regurgitation in dogs. The applicability of this indicator-dilution method to the study of clinical aortic reguragitation merits further study.
One-Year Survival Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock, and its Relation to Early Revascularization
Berger, Peter B. , Tuttle, Robert H., Holmes, David R. , Aylward, Philip E. , Horgan, John, Topol, Eric J. , Califf, Robert M.

Mayo Clinic

Circulation | June 12, 2012 | Volume: 99 | Issue: 7 | Pages: 873-878

10.1161/01.cir.99.7.873 | PMID 10027808 Get It

Background —Although 30-day survival is increased in patients with acute myocardial infarction complicated by cardiogenic shock who undergo coronary revascularization, the longer-term outcome in such patients and the duration of benefit from revascularization are unknown. Methods and Results —We analyzed 30-day survivors of acute myocardial infarction in the Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial and identified 36 333 who had not had cardiogenic shock (systolic blood pressure <90 mm Hg for ≥1 hour, group 1) and 1321 patients who had shock (group 2). Group 2 patients were older and sicker. At 1 year, 97.4% of group 1 patients were alive versus 88.0% of group 2 ( P =0.0001). Among group 2 patients, 578 (44%) had undergone revascularization within 30 days (group 2A) and 728 (56%) had not (group 2B). Revascularization was not required by protocol but was selected by the attending physicians. At 1 year, 91.7% of group 2A patients were alive versus 85.3% of group 2B ( P =0.0003). With the use of multivariable logistic regression analysis to adjust for differences in baseline characteristics of shock patients alive at 30 days, revascularization within 30 days was independently associated with reduced 1-year mortality (odds ratio 0.6, [95% confidence interval 0.4, 0.9], P =0.007). Conclusions —Most patients (88%) with acute myocardial infarction complicated by cardiogenic shock who are alive at 30 days survived at least 1 year. Shock patients who underwent revascularization within 30 days had improved survival at 1 year compared with shock patients who did not receive revascularization, even after adjustment for differences in baseline characteristics between the 2 groups.
Safety and Efficacy of Ticlopidine for Only 2 Weeks After Successful Intracoronary Stent Placement
Berger, Peter B. , Bell, Malcolm R. , Hasdai, David , Grill, Diane E. , Melby, Steve, Holmes, David R.

Mayo Clinic

Circulation | June 12, 2012 | Volume: 99 | Issue: 2 | Pages: 248-253

10.1161/01.cir.99.2.248 | PMID 9892591 Get It

Background —In patients receiving intracoronary stents, stent thrombosis is reduced when ticlopidine therapy is combined with aspirin after the procedure. However, ticlopidine causes neutropenia in 1% of patients when administered for >2 weeks, and little is known about the duration that ticlopidine needs be administered to prevent stent thrombosis. Methods and Results —We analyzed 827 patients undergoing successful stent placement in 1061 coronary segments at Mayo Clinic who were treated between May 1, 1996, and October 31, 1997. Chronic warfarin therapy, cardiogenic shock, and enrollment in research protocols requiring 4 weeks of ticlopidine were exclusion criteria; ticlopidine was discontinued after 14 days in all remaining patients. The mean age of the study population was 64±11 years; 49% had suffered a prior infarction, 20% had undergone coronary artery bypass surgery, and 65% had multivessel disease. The indication for stent placement was dissection or abrupt closure in 31% of patients and suboptimal results from balloon angioplasty in 18%. Placement was elective in 51% of patients, and 10.3% of patients were treated within 12 hours of an acute myocardial infarction. Mean nominal stent size was 3.3±0.5 mm. High-pressure inflations (≥12 atm) were performed in all patients (mean, 17±4 atm). Intravascular ultrasound was used to facilitate stent placement in 8.8% of patients. Abciximab was administered to 38% of patients; 11% of patients who were at increased risk of stent thrombosis were treated with enoxaparin for 10 to 14 days. Adverse cardiovascular events in the 14 days after stent placement occurred in 11 patients (1.3%). Two patients died of nonischemic causes (sepsis and renal failure) in the 15th through 30th days after ticlopidine was stopped. However, there were no cardiovascular deaths, myocardial infarctions, coronary artery bypass operations, or repeat angioplasty procedures between the 15th and 30th days; stent thrombosis did not occur in any patient after ticlopidine had been stopped. No patient developed neutropenia, although 1.8% of the first 489 patients who were closely monitored for side effects from ticlopidine developed side effects requiring its discontinuation, and milder side effects occurred in 4.7%. Conclusions —In patients receiving intracoronary stents, the discontinuation of ticlopidine therapy 14 days after stent placement is associated with a very low frequency of stent thrombosis and other adverse events.
Frequency of Atrial Septal Aneurysms in Patients With Cerebral Ischemic Events
Agmon, Yoram , Khandheria, Bijoy K. , Meissner, Irene, Gentile, Federico , Whisnant, Jack P., Sicks, JoRean D., O’Fallon, W. Michael, Covalt, Jody L., Wiebers, David O. , Seward, James B.

Mayo Clinic

Circulation | June 12, 2012 | Volume: 99 | Issue: 15 | Pages: 1942-1944

10.1161/01.cir.99.15.1942 | PMID 10208995 Get It

Background —Atrial septal aneurysm (ASA) is a putative risk factor for cardioembolism. However, the frequency of ASA in the general population has not been adequately determined. Therefore, the frequency in patients with cerebral ischemic events, compared with the frequency in the general population, is poorly defined. We sought to determine the frequency of ASA in the general population and to compare the frequency of ASA in patients with cerebral ischemic events with the frequency in the general population. Methods and Results —The frequency of ASA in the population was determined in 363 subjects, a sample of the participants in the Stroke Prevention: Assessment of Risk in a Community study (control subjects), and was compared with the frequency in 355 age- and sex-matched patients undergoing transesophageal echocardiography in search of a cardiac source of embolism after a focal cerebral ischemic event. The proportion with ASA was 7.9% in patients versus 2.2% in control subjects ( P =0.002; odds ratio of ASA, 3.65; 95% CI, 1.64 to 8.13, in patients versus control subjects). Patent foramen ovale (PFO) was detected with contrast injections in 56% of subjects with ASA. The presence of ASA predicted the presence of PFO (odds ratio of PFO, 4.57; 95% CI, 2.18 to 9.57, in subjects with versus those without ASA). In 86% of subjects with ASA and cerebral ischemia, transesophageal echocardiography did not detect an alternative source of cardioembolism other than an associated PFO. Conclusions —The prevalence of ASA based on this population-based study is 2.2%. The frequency of ASA is relatively higher in patients evaluated with transesophageal echocardiography after a cerebral ischemic event. ASA is frequently associated with PFO, suggesting paradoxical embolism as a mechanism of cardioembolism. In patients with cerebral ischemia and ASA, ASA (with or without PFO) commonly is the only potential cardioembolic source detected with transesophageal echocardiography.
Chronic Endothelin Receptor Antagonism Preserves Coronary Endothelial Function in Experimental Hypercholesterolemia
Best, Patricia J.M. , McKenna, Charles J., Hasdai, David, Holmes, David R. , Lerman, Amir

Mayo Clinic

Circulation | June 12, 2012 | Volume: 99 | Issue: 13 | Pages: 1747-1752

10.1161/01.cir.99.13.1747 | PMID 10190886 Get It

Background—Endothelin-1 (ET-1) is an endothelium-derived peptide that constricts coronary vessels through stimulation of the ET-A and ET-B receptors. Experimental porcine hypercholesterolemia is associated with impaired coronary endothelial function and elevated ET-1 concentrations. This study was designed to test the hypothesis that chronic endothelin receptor antagonism preserves coronary endothelial function in experimental hypercholesterolemia.Methods and Results—Acetylcholine (10−6to 10−4mol/L) was serially infused into the left anterior descending coronary artery in pigs at baseline and after 12 weeks of a high-cholesterol diet. In the interim, the animals were randomized to 3 groups: Group 1 received no therapy, group 2 received 3 mg/kg per day RO 48-5695, a combined ET-A/ET-B receptor antagonist, and group 3 received 4 mg/kg per day ABT-627, a selective ET-A receptor antagonist. Percent change in coronary artery diameter, coronary blood flow, and coronary vascular resistance were calculated on the basis of quantitative coronary angiography and intracoronary Doppler. At 12 weeks, total cholesterol was significantly and similarly increased in all groups. Chronic endothelin receptor antagonism significantly increased coronary blood flow in response to acetylcholine at 12 weeks (group 1: −41.6%±10.7%, group 2: −4.7%±11.9%, group 3: 11.4%±7.4%).Conclusions—Chronic endothelin receptor antagonism preserves coronary endothelial function in experimental hypercholesterolemia. This study supports the role for ET-1 in the pathogenesis of endothelial function. Moreover, endothelin receptor antagonists may have a therapeutic role by maintaining coronary endothelial function in pathophysiological states.